Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 study evaluating epoetin alfa vs placebo to reduce blood transfusions and severe anemia around total hip replacement; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Anemia | Phase 2 | Status: COMPLETED